Project Grant F32AI191488
- This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855), is supporting research to investigate the assembly pathway of mycomembrane proteins in bacterial cell envelopes. The research aims to characterize the role of mycoloyltransferase enzymes in the transport and assembly of mycolate outer membrane proteins (MOMPs), which are critical for mediating interactions between...
- This $3,262,539 Project Grant was awarded on August 1, 2025 by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855). The grant supports research at Yale University to elucidate the molecular mechanisms underlying the assembly of the multi-layered cell envelope of Mycobacterium tuberculosis (MTB), a critical barrier to antibiotics and an important target for drug development. The key objectives are to...
- This $492,000 Project Grant was awarded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) to The Regents of the University of California, San Francisco (UCSF). The grant is focused on the structural characterization of the elongasome and divisome protein complexes in the tuberculosis-causing bacterium Mycobacterium tuberculosis (MTB) and the non-pathogenic model Mycobacterium smegmatis. The research...
- This Project Grant award, funded by the National Institute of General Medical Sciences (NIGMS) under the Biomedical Research and Research Training program (CFDA 93.859), supports research to investigate the molecular mechanisms of two lipid transporter families involved in cell wall biosynthesis. The $394,068 award, effective from June 1, 2025 through April 30, 2030, will enable researchers at the University of Georgia Research Foundation to study the structure, function, and ion-coupled...
- This Project Grant award of $445,084.00 from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), is funding research to track the secretion of ESX-1 substrates through the cell envelope of mycobacteria. The objective is to develop tools to localize components of the ESX-1 secretion system to the mycobacterial cell wall and surface, in order to elucidate the mechanism of ESX-mediated protein secretion. The...
- This three-year Project Grant from the National Science Foundation's Division of Molecular and Cellular Biosciences totals $1,512,792 to fund research at Louisiana State University examining the gene regulatory networks affected by purine catabolites in bacterial pathogens. The research aims to identify additional transcription factors in Burkholderia thailandensis responsive to urate and xanthine, which accumulate in host tissues during infection due to production of reactive oxygen species....
- This Project Grant award of $831,472.00 from the National Institute of General Medical Sciences (NIGMS), under the Biomedical Research and Research Training program (CFDA 93.859), supports fundamental scientific research on lipoprotein trafficking to the bacterial outer membrane in gram-negative bacteria. The research aims to uncover the factors responsible for lipoprotein trafficking independent of the previously known "LOL pathway", and understand why multiple routes exist for this...
- This Project Grant award for $423,500 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research Federal Grant Program (CFDA 93.855) aims to explore phenylalanine biosynthesis as a novel drug target for treating tuberculosis (TB) caused by Mycobacterium tuberculosis (MTB). The research will develop conditional MTB strains to determine if MTB requires phenylalanine synthesis for growth during infection, and how inhibiting this pathway...
- This Project Grant award, funded by the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855), aims to define the mechanisms by which CD4 T cells provide help to myeloid cells to activate antibacterial effector mechanisms against Mycobacterium tuberculosis (MTB) infection. The $2,863,501 award, spanning August 1, 2025 to July 31, 2029, will support research at the Regents of the University of Minnesota to...
- This federal Project Grant award of $236,250 from the National Institute of Allergy and Infectious Diseases (NIAID) under the Allergy and Infectious Diseases Research program (CFDA 93.855) aims to identify small molecule inhibitors of the Mycobacterium tuberculosis (MTB) type VII secretion systems (T7SS), which are critical virulence determinants and novel drug targets for tuberculosis (TB). The researchers plan to use split-luciferase based high-throughput screening assays targeting the ESX-1...
INVESTIGATION OF FACTORS INVOLVED IN ASSEMBLY OF THE MYCOLATA ENVELOPE - PROJECT SUMMARY BACTERIA SURROUND THEMSELVES WITH COMPLEX CELL STRUCTURES CALLED CELL ENVELOPES TO PRESERVE CELL INTEGRITY, DEFEND AGAINST EXTERNAL THREATS, AND TO FACILITATE UPTAKE AND METABOLISM OF NUTRIENTS ESSENTIAL FOR BACTERIAL GROWTH AND SURVIVAL WITHIN THE CELL'S ENVIRONMENT. BACTERIA OF THE ORDER CORYNEBACTERIALES POSSESS UNIQUE MULTILAYERED ENVELOPES CONSISTING OF AN ARABINOGALACTAN-PEPTIDOGLYCAN CELL WALL AND AN OUTER MEMBRANE CALLED THE MYCOMEMBRANE (MM) COMPOSED OF LIPIDS CALLED MYCOLIC ACIDS. MYCOLIC ACIDS ARE A HALLMARK FEATURE OF THESE BACTERIA AND GREATLY CONTRIBUTE TO THE PATHOGENICITY OF SOME CORYNEBACTERIAL, NOCARDIAL, AND MYCOBACTERIAL SPECIES, SUCH AS CORYNEBACTERIUM DIPTHERIAE AND MYCOBACTERIUM TUBERCULOSIS. MUCH REMAINS TO BE DISCOVERED ABOUT THE MECHANISMS INVOLVED IN THE BIOGENESIS AND MODIFICATION OF THIS UNIQUE ENVELOPE ARCHITECTURE. IN PARTICULAR, IT IS UNCLEAR HOW THESE ORGANISMS COORDINATE THE SYNTHESIS OF THE DIFFERENT ENVELOPE LAYERS DURING BACTERIAL GROWTH. MY PRELIMINARY DATA SUGGEST THAT TMAT, AN ENZYME INVOLVED IN MYCOLIC ACID TRANSPORT TO THE MYCOMEMBRANE IS REGULATED BY AFTD, AN ARABINOSYLTRANSFERASE THAT AIDS IN CONSTRUCTION OF THE ARABINOGALACTAN LAYER. THESE DATA SUGGEST COORDINATED REGULATION OF THE SYNTHESIS OF THE DIFFERENT CELL WALL LAYERS. OVERALL, THIS WORK WILL REVEAL FUNDAMENTAL MECHANISMS IMPORTANT FOR REGULATION AND SYNTHESIS OF AN ESSENTIAL COMPONENT AND ATTRACTIVE DRUG TARGET OF MYCOBACTERIAL SPECIES. THE SPECIFIC AIMS OF THIS F32 APPLICATION ARE: AIM 1: ELUCIDATE THE ROLE OF THE TMAT-AFTD COMPLEX IN ASSEMBLY OF THE MYCOLATA ENVELOPE AIM 2: CHARACTERIZE NEW FACTORS REQUIRED FOR MYCOMEMBRANE BIOGENESIS
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $80.2k | 8/29/25 |